Case report: Venetoclax plus Azacitidine in treatment of acute undifferentiated leukemia

This study is the first to report an AUL patient treated with the "VA" scheme and achieved CR. Our result preliminarily suggested the effectiveness and safety of the "VA" scheme in AUL treatment, but validation is required in more clinical samples. The "VA" scheme provides a new treatment option for AUL patients and deserves further clinical promotion.PMID:38095304 | DOI:10.1080/16078454.2023.2293494

Source: Hematology - December 14, 2023 Category: Hematology Authors: Yu Cui Ruihua Mi Lin Chen Lin Wang Dongbei Li Xudong Wei Source Type: research